Financing Life Sciences 2020
Erscheinungsdatum: 20. März
Titelthema: Financing Life Sciences (englischsprachig)
Exciting technologies – successful investors – deals – exits – IPO. Investments in life sciences and medical biotechnology remain challenging in Germany even though those fields are and will be the key industries in the near future. Development time and licensing progress take too long and scare investors to keep trying. Local financing gaps, mainly starting at series B attract foreign investors, particularly from the US and Asia promising technology to foreign markets.